nodes	percent_of_prediction	percent_of_DWPC	metapath
Dapiprazole—ADRA1D—Bromocriptine—type 2 diabetes mellitus	0.357	0.434	CbGbCtD
Dapiprazole—ADRA1B—Bromocriptine—type 2 diabetes mellitus	0.26	0.316	CbGbCtD
Dapiprazole—ADRA1A—Bromocriptine—type 2 diabetes mellitus	0.205	0.249	CbGbCtD
Dapiprazole—Risperidone—ADRA2A—type 2 diabetes mellitus	0.00297	0.42	CrCbGaD
Dapiprazole—Risperidone—HTR2C—type 2 diabetes mellitus	0.00273	0.387	CrCbGaD
Dapiprazole—Risperidone—CYP3A4—type 2 diabetes mellitus	0.00136	0.193	CrCbGaD
Dapiprazole—ADRA1B—Signaling Pathways—RBP4—type 2 diabetes mellitus	5.05e-05	0.000295	CbGpPWpGaD
Dapiprazole—ADRA1B—Signaling Pathways—GLP1R—type 2 diabetes mellitus	5.05e-05	0.000295	CbGpPWpGaD
Dapiprazole—ADRA1D—Signaling by GPCR—C3—type 2 diabetes mellitus	5.04e-05	0.000295	CbGpPWpGaD
Dapiprazole—ADRA1B—Signaling by GPCR—AVP—type 2 diabetes mellitus	5.04e-05	0.000294	CbGpPWpGaD
Dapiprazole—ADRA1B—Signaling by GPCR—MMP3—type 2 diabetes mellitus	5.04e-05	0.000294	CbGpPWpGaD
Dapiprazole—ADRA1A—Signaling Pathways—CRHR1—type 2 diabetes mellitus	5.03e-05	0.000294	CbGpPWpGaD
Dapiprazole—ADRA1B—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—type 2 diabetes mellitus	5.03e-05	0.000294	CbGpPWpGaD
Dapiprazole—ADRA1B—GPCR downstream signaling—ADCY5—type 2 diabetes mellitus	5.01e-05	0.000293	CbGpPWpGaD
Dapiprazole—ADRA1D—Signaling Pathways—EDNRB—type 2 diabetes mellitus	5.01e-05	0.000293	CbGpPWpGaD
Dapiprazole—ADRA1A—GPCR downstream signaling—GNB3—type 2 diabetes mellitus	4.99e-05	0.000292	CbGpPWpGaD
Dapiprazole—ADRA1B—Signaling Pathways—CCKAR—type 2 diabetes mellitus	4.97e-05	0.00029	CbGpPWpGaD
Dapiprazole—ADRA1A—GPCR downstream signaling—AVP—type 2 diabetes mellitus	4.93e-05	0.000288	CbGpPWpGaD
Dapiprazole—ADRA1D—GPCR downstream signaling—PRKCB—type 2 diabetes mellitus	4.87e-05	0.000285	CbGpPWpGaD
Dapiprazole—ADRA1D—Signaling Pathways—PSMD6—type 2 diabetes mellitus	4.86e-05	0.000284	CbGpPWpGaD
Dapiprazole—ADRA1D—Signaling Pathways—HTR2C—type 2 diabetes mellitus	4.86e-05	0.000284	CbGpPWpGaD
Dapiprazole—ADRA1D—Signaling by GPCR—AGT—type 2 diabetes mellitus	4.79e-05	0.00028	CbGpPWpGaD
Dapiprazole—ADRA1B—Signaling by GPCR—EDN1—type 2 diabetes mellitus	4.79e-05	0.00028	CbGpPWpGaD
Dapiprazole—ADRA1D—Signaling Pathways—EDNRA—type 2 diabetes mellitus	4.73e-05	0.000276	CbGpPWpGaD
Dapiprazole—ADRA1B—GPCR downstream signaling—CCR5—type 2 diabetes mellitus	4.72e-05	0.000276	CbGpPWpGaD
Dapiprazole—ADRA1D—Signaling by GPCR—CALM1—type 2 diabetes mellitus	4.71e-05	0.000275	CbGpPWpGaD
Dapiprazole—ADRA1D—Signaling Pathways—CYBA—type 2 diabetes mellitus	4.71e-05	0.000275	CbGpPWpGaD
Dapiprazole—ADRA1A—GPCR downstream signaling—EDN1—type 2 diabetes mellitus	4.69e-05	0.000274	CbGpPWpGaD
Dapiprazole—ADRA1A—Signaling Pathways—PRKAA1—type 2 diabetes mellitus	4.64e-05	0.000271	CbGpPWpGaD
Dapiprazole—ADRA1D—Signaling Pathways—ADRA2A—type 2 diabetes mellitus	4.63e-05	0.000271	CbGpPWpGaD
Dapiprazole—ADRA1D—Signaling Pathways—PLAT—type 2 diabetes mellitus	4.61e-05	0.000269	CbGpPWpGaD
Dapiprazole—ADRA1D—Signaling Pathways—GHRL—type 2 diabetes mellitus	4.61e-05	0.000269	CbGpPWpGaD
Dapiprazole—ADRA1B—GPCR downstream signaling—C3—type 2 diabetes mellitus	4.61e-05	0.000269	CbGpPWpGaD
Dapiprazole—ADRA1A—Signaling Pathways—SPRY2—type 2 diabetes mellitus	4.6e-05	0.000269	CbGpPWpGaD
Dapiprazole—ADRA1A—Signaling Pathways—MTNR1B—type 2 diabetes mellitus	4.6e-05	0.000269	CbGpPWpGaD
Dapiprazole—ADRA1D—Signaling Pathways—CALCA—type 2 diabetes mellitus	4.55e-05	0.000266	CbGpPWpGaD
Dapiprazole—ADRA1B—Signaling by GPCR—ADCY5—type 2 diabetes mellitus	4.55e-05	0.000266	CbGpPWpGaD
Dapiprazole—ADRA1A—Signaling by GPCR—GNB3—type 2 diabetes mellitus	4.53e-05	0.000265	CbGpPWpGaD
Dapiprazole—ADRA1B—Signaling Pathways—ATP2A2—type 2 diabetes mellitus	4.5e-05	0.000263	CbGpPWpGaD
Dapiprazole—ADRA1A—Signaling Pathways—GLP1R—type 2 diabetes mellitus	4.48e-05	0.000262	CbGpPWpGaD
Dapiprazole—ADRA1A—Signaling Pathways—RBP4—type 2 diabetes mellitus	4.48e-05	0.000262	CbGpPWpGaD
Dapiprazole—ADRA1A—Signaling by GPCR—AVP—type 2 diabetes mellitus	4.47e-05	0.000262	CbGpPWpGaD
Dapiprazole—ADRA1A—Signaling by GPCR—MMP3—type 2 diabetes mellitus	4.47e-05	0.000262	CbGpPWpGaD
Dapiprazole—ADRA1B—Signaling Pathways—IAPP—type 2 diabetes mellitus	4.47e-05	0.000261	CbGpPWpGaD
Dapiprazole—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—type 2 diabetes mellitus	4.46e-05	0.000261	CbGpPWpGaD
Dapiprazole—ADRA1A—GPCR downstream signaling—ADCY5—type 2 diabetes mellitus	4.45e-05	0.00026	CbGpPWpGaD
Dapiprazole—ADRA1B—Signaling Pathways—INSR—type 2 diabetes mellitus	4.44e-05	0.00026	CbGpPWpGaD
Dapiprazole—ADRA1D—Signaling by GPCR—PRKCB—type 2 diabetes mellitus	4.43e-05	0.000259	CbGpPWpGaD
Dapiprazole—ADRA1A—Signaling Pathways—CCKAR—type 2 diabetes mellitus	4.41e-05	0.000258	CbGpPWpGaD
Dapiprazole—ADRA1B—GPCR downstream signaling—AGT—type 2 diabetes mellitus	4.38e-05	0.000256	CbGpPWpGaD
Dapiprazole—ADRA1B—Signaling Pathways—TRPC6—type 2 diabetes mellitus	4.37e-05	0.000255	CbGpPWpGaD
Dapiprazole—ADRA1B—Signaling by GPCR—PPP2CA—type 2 diabetes mellitus	4.36e-05	0.000255	CbGpPWpGaD
Dapiprazole—ADRA1B—Signaling Pathways—AGTR2—type 2 diabetes mellitus	4.34e-05	0.000254	CbGpPWpGaD
Dapiprazole—ADRA1D—Signaling Pathways—TCF7L2—type 2 diabetes mellitus	4.29e-05	0.000251	CbGpPWpGaD
Dapiprazole—ADRA1B—Signaling by GPCR—CCR5—type 2 diabetes mellitus	4.28e-05	0.00025	CbGpPWpGaD
Dapiprazole—ADRA1D—GPCR downstream signaling—AKT2—type 2 diabetes mellitus	4.27e-05	0.00025	CbGpPWpGaD
Dapiprazole—ADRA1A—Signaling by GPCR—EDN1—type 2 diabetes mellitus	4.25e-05	0.000249	CbGpPWpGaD
Dapiprazole—ADRA1D—Signaling Pathways—GCG—type 2 diabetes mellitus	4.22e-05	0.000246	CbGpPWpGaD
Dapiprazole—ADRA1D—Signaling Pathways—PTPN1—type 2 diabetes mellitus	4.22e-05	0.000246	CbGpPWpGaD
Dapiprazole—ADRA1A—GPCR downstream signaling—CCR5—type 2 diabetes mellitus	4.19e-05	0.000245	CbGpPWpGaD
Dapiprazole—ADRA1B—Signaling by GPCR—C3—type 2 diabetes mellitus	4.18e-05	0.000245	CbGpPWpGaD
Dapiprazole—ADRA1B—Signaling Pathways—EDNRB—type 2 diabetes mellitus	4.16e-05	0.000243	CbGpPWpGaD
Dapiprazole—ADRA1D—Signaling Pathways—RASGRP1—type 2 diabetes mellitus	4.15e-05	0.000242	CbGpPWpGaD
Dapiprazole—ADRA1D—Signaling Pathways—NOTCH2—type 2 diabetes mellitus	4.13e-05	0.000242	CbGpPWpGaD
Dapiprazole—ADRA1A—GPCR downstream signaling—C3—type 2 diabetes mellitus	4.09e-05	0.000239	CbGpPWpGaD
Dapiprazole—ADRA1B—GPCR downstream signaling—PRKCB—type 2 diabetes mellitus	4.05e-05	0.000237	CbGpPWpGaD
Dapiprazole—ADRA1A—Signaling by GPCR—ADCY5—type 2 diabetes mellitus	4.04e-05	0.000236	CbGpPWpGaD
Dapiprazole—ADRA1B—Signaling Pathways—HTR2C—type 2 diabetes mellitus	4.04e-05	0.000236	CbGpPWpGaD
Dapiprazole—ADRA1B—Signaling Pathways—PSMD6—type 2 diabetes mellitus	4.04e-05	0.000236	CbGpPWpGaD
Dapiprazole—ADRA1A—Signaling Pathways—ATP2A2—type 2 diabetes mellitus	4e-05	0.000234	CbGpPWpGaD
Dapiprazole—ADRA1B—Signaling by GPCR—AGT—type 2 diabetes mellitus	3.98e-05	0.000232	CbGpPWpGaD
Dapiprazole—ADRA1A—Signaling Pathways—IAPP—type 2 diabetes mellitus	3.97e-05	0.000232	CbGpPWpGaD
Dapiprazole—ADRA1A—Signaling Pathways—INSR—type 2 diabetes mellitus	3.95e-05	0.000231	CbGpPWpGaD
Dapiprazole—ADRA1D—Signaling by GPCR—CCL2—type 2 diabetes mellitus	3.95e-05	0.000231	CbGpPWpGaD
Dapiprazole—ADRA1B—Signaling Pathways—EDNRA—type 2 diabetes mellitus	3.93e-05	0.000229	CbGpPWpGaD
Dapiprazole—ADRA1B—Signaling by GPCR—CALM1—type 2 diabetes mellitus	3.91e-05	0.000229	CbGpPWpGaD
Dapiprazole—ADRA1B—Signaling Pathways—CYBA—type 2 diabetes mellitus	3.91e-05	0.000228	CbGpPWpGaD
Dapiprazole—ADRA1A—GPCR downstream signaling—AGT—type 2 diabetes mellitus	3.89e-05	0.000227	CbGpPWpGaD
Dapiprazole—ADRA1A—Signaling Pathways—TRPC6—type 2 diabetes mellitus	3.88e-05	0.000227	CbGpPWpGaD
Dapiprazole—ADRA1D—Signaling by GPCR—AKT2—type 2 diabetes mellitus	3.88e-05	0.000227	CbGpPWpGaD
Dapiprazole—ADRA1A—Signaling by GPCR—PPP2CA—type 2 diabetes mellitus	3.87e-05	0.000226	CbGpPWpGaD
Dapiprazole—ADRA1D—GPCR downstream signaling—PIK3R1—type 2 diabetes mellitus	3.87e-05	0.000226	CbGpPWpGaD
Dapiprazole—ADRA1A—Signaling Pathways—AGTR2—type 2 diabetes mellitus	3.86e-05	0.000225	CbGpPWpGaD
Dapiprazole—ADRA1B—Signaling Pathways—ADRA2A—type 2 diabetes mellitus	3.84e-05	0.000225	CbGpPWpGaD
Dapiprazole—ADRA1B—Signaling Pathways—PLAT—type 2 diabetes mellitus	3.83e-05	0.000224	CbGpPWpGaD
Dapiprazole—ADRA1B—Signaling Pathways—GHRL—type 2 diabetes mellitus	3.83e-05	0.000224	CbGpPWpGaD
Dapiprazole—ADRA1A—Signaling by GPCR—CCR5—type 2 diabetes mellitus	3.8e-05	0.000222	CbGpPWpGaD
Dapiprazole—ADRA1B—Signaling Pathways—CALCA—type 2 diabetes mellitus	3.78e-05	0.000221	CbGpPWpGaD
Dapiprazole—ADRA1A—Signaling by GPCR—C3—type 2 diabetes mellitus	3.72e-05	0.000217	CbGpPWpGaD
Dapiprazole—ADRA1A—Signaling Pathways—EDNRB—type 2 diabetes mellitus	3.69e-05	0.000216	CbGpPWpGaD
Dapiprazole—ADRA1B—Signaling by GPCR—PRKCB—type 2 diabetes mellitus	3.67e-05	0.000215	CbGpPWpGaD
Dapiprazole—ADRA1D—Signaling Pathways—TGFBR2—type 2 diabetes mellitus	3.67e-05	0.000214	CbGpPWpGaD
Dapiprazole—ADRA1D—Signaling Pathways—GNB3—type 2 diabetes mellitus	3.63e-05	0.000212	CbGpPWpGaD
Dapiprazole—ADRA1A—GPCR downstream signaling—PRKCB—type 2 diabetes mellitus	3.59e-05	0.00021	CbGpPWpGaD
Dapiprazole—ADRA1D—Signaling Pathways—AVP—type 2 diabetes mellitus	3.58e-05	0.00021	CbGpPWpGaD
Dapiprazole—ADRA1A—Signaling Pathways—HTR2C—type 2 diabetes mellitus	3.58e-05	0.00021	CbGpPWpGaD
Dapiprazole—ADRA1A—Signaling Pathways—PSMD6—type 2 diabetes mellitus	3.58e-05	0.00021	CbGpPWpGaD
Dapiprazole—ADRA1D—Signaling Pathways—MMP3—type 2 diabetes mellitus	3.58e-05	0.00021	CbGpPWpGaD
Dapiprazole—ADRA1D—Signaling Pathways—IGF2—type 2 diabetes mellitus	3.57e-05	0.000209	CbGpPWpGaD
Dapiprazole—ADRA1B—Signaling Pathways—TCF7L2—type 2 diabetes mellitus	3.56e-05	0.000208	CbGpPWpGaD
Dapiprazole—ADRA1D—Signaling Pathways—CDKN2B—type 2 diabetes mellitus	3.55e-05	0.000208	CbGpPWpGaD
Dapiprazole—ADRA1B—GPCR downstream signaling—AKT2—type 2 diabetes mellitus	3.54e-05	0.000207	CbGpPWpGaD
Dapiprazole—ADRA1A—Signaling by GPCR—AGT—type 2 diabetes mellitus	3.53e-05	0.000206	CbGpPWpGaD
Dapiprazole—ADRA1D—Signaling by GPCR—PIK3R1—type 2 diabetes mellitus	3.52e-05	0.000206	CbGpPWpGaD
Dapiprazole—ADRA1B—Signaling Pathways—GCG—type 2 diabetes mellitus	3.5e-05	0.000205	CbGpPWpGaD
Dapiprazole—ADRA1B—Signaling Pathways—PTPN1—type 2 diabetes mellitus	3.5e-05	0.000205	CbGpPWpGaD
Dapiprazole—ADRA1A—Signaling Pathways—EDNRA—type 2 diabetes mellitus	3.49e-05	0.000204	CbGpPWpGaD
Dapiprazole—ADRA1A—Signaling by GPCR—CALM1—type 2 diabetes mellitus	3.47e-05	0.000203	CbGpPWpGaD
Dapiprazole—ADRA1A—Signaling Pathways—CYBA—type 2 diabetes mellitus	3.47e-05	0.000203	CbGpPWpGaD
Dapiprazole—ADRA1D—Signaling Pathways—APOB—type 2 diabetes mellitus	3.46e-05	0.000203	CbGpPWpGaD
Dapiprazole—ADRA1D—Signaling Pathways—IGF1R—type 2 diabetes mellitus	3.45e-05	0.000202	CbGpPWpGaD
Dapiprazole—ADRA1B—Signaling Pathways—RASGRP1—type 2 diabetes mellitus	3.44e-05	0.000201	CbGpPWpGaD
Dapiprazole—ADRA1B—Signaling Pathways—NOTCH2—type 2 diabetes mellitus	3.43e-05	0.000201	CbGpPWpGaD
Dapiprazole—ADRA1A—Signaling Pathways—ADRA2A—type 2 diabetes mellitus	3.41e-05	0.000199	CbGpPWpGaD
Dapiprazole—ADRA1D—Signaling Pathways—EDN1—type 2 diabetes mellitus	3.41e-05	0.000199	CbGpPWpGaD
Dapiprazole—ADRA1A—Signaling Pathways—PLAT—type 2 diabetes mellitus	3.4e-05	0.000199	CbGpPWpGaD
Dapiprazole—ADRA1A—Signaling Pathways—GHRL—type 2 diabetes mellitus	3.4e-05	0.000199	CbGpPWpGaD
Dapiprazole—ADRA1A—Signaling Pathways—CALCA—type 2 diabetes mellitus	3.36e-05	0.000196	CbGpPWpGaD
Dapiprazole—ADRA1D—Signaling Pathways—LPL—type 2 diabetes mellitus	3.31e-05	0.000193	CbGpPWpGaD
Dapiprazole—ADRA1B—Signaling by GPCR—CCL2—type 2 diabetes mellitus	3.27e-05	0.000191	CbGpPWpGaD
Dapiprazole—ADRA1A—Signaling by GPCR—PRKCB—type 2 diabetes mellitus	3.26e-05	0.000191	CbGpPWpGaD
Dapiprazole—ADRA1D—Signaling Pathways—ADCY5—type 2 diabetes mellitus	3.24e-05	0.000189	CbGpPWpGaD
Dapiprazole—ADRA1B—Signaling by GPCR—AKT2—type 2 diabetes mellitus	3.22e-05	0.000188	CbGpPWpGaD
Dapiprazole—ADRA1B—GPCR downstream signaling—PIK3R1—type 2 diabetes mellitus	3.21e-05	0.000188	CbGpPWpGaD
Dapiprazole—ADRA1A—Signaling Pathways—TCF7L2—type 2 diabetes mellitus	3.16e-05	0.000185	CbGpPWpGaD
Dapiprazole—ADRA1A—GPCR downstream signaling—AKT2—type 2 diabetes mellitus	3.15e-05	0.000184	CbGpPWpGaD
Dapiprazole—ADRA1A—Signaling Pathways—GCG—type 2 diabetes mellitus	3.11e-05	0.000182	CbGpPWpGaD
Dapiprazole—ADRA1A—Signaling Pathways—PTPN1—type 2 diabetes mellitus	3.11e-05	0.000182	CbGpPWpGaD
Dapiprazole—ADRA1D—Signaling Pathways—PPP2CA—type 2 diabetes mellitus	3.1e-05	0.000181	CbGpPWpGaD
Dapiprazole—ADRA1A—Signaling Pathways—RASGRP1—type 2 diabetes mellitus	3.06e-05	0.000179	CbGpPWpGaD
Dapiprazole—ADRA1D—Signaling Pathways—CCR5—type 2 diabetes mellitus	3.05e-05	0.000178	CbGpPWpGaD
Dapiprazole—ADRA1A—Signaling Pathways—NOTCH2—type 2 diabetes mellitus	3.05e-05	0.000178	CbGpPWpGaD
Dapiprazole—ADRA1B—Signaling Pathways—TGFBR2—type 2 diabetes mellitus	3.04e-05	0.000178	CbGpPWpGaD
Dapiprazole—ADRA1B—Signaling Pathways—GNB3—type 2 diabetes mellitus	3.02e-05	0.000176	CbGpPWpGaD
Dapiprazole—ADRA1D—Signaling Pathways—C3—type 2 diabetes mellitus	2.98e-05	0.000174	CbGpPWpGaD
Dapiprazole—ADRA1B—Signaling Pathways—AVP—type 2 diabetes mellitus	2.98e-05	0.000174	CbGpPWpGaD
Dapiprazole—ADRA1B—Signaling Pathways—MMP3—type 2 diabetes mellitus	2.98e-05	0.000174	CbGpPWpGaD
Dapiprazole—ADRA1B—Signaling Pathways—IGF2—type 2 diabetes mellitus	2.96e-05	0.000173	CbGpPWpGaD
Dapiprazole—ADRA1B—Signaling Pathways—CDKN2B—type 2 diabetes mellitus	2.95e-05	0.000172	CbGpPWpGaD
Dapiprazole—ADRA1B—Signaling by GPCR—PIK3R1—type 2 diabetes mellitus	2.92e-05	0.000171	CbGpPWpGaD
Dapiprazole—ADRA1A—Signaling by GPCR—CCL2—type 2 diabetes mellitus	2.91e-05	0.00017	CbGpPWpGaD
Dapiprazole—ADRA1B—Signaling Pathways—APOB—type 2 diabetes mellitus	2.88e-05	0.000168	CbGpPWpGaD
Dapiprazole—ADRA1B—Signaling Pathways—IGF1R—type 2 diabetes mellitus	2.86e-05	0.000167	CbGpPWpGaD
Dapiprazole—ADRA1A—Signaling by GPCR—AKT2—type 2 diabetes mellitus	2.86e-05	0.000167	CbGpPWpGaD
Dapiprazole—ADRA1A—GPCR downstream signaling—PIK3R1—type 2 diabetes mellitus	2.85e-05	0.000167	CbGpPWpGaD
Dapiprazole—ADRA1D—Signaling Pathways—HIF1A—type 2 diabetes mellitus	2.84e-05	0.000166	CbGpPWpGaD
Dapiprazole—ADRA1D—Signaling Pathways—IRS2—type 2 diabetes mellitus	2.83e-05	0.000166	CbGpPWpGaD
Dapiprazole—ADRA1D—Signaling Pathways—AGT—type 2 diabetes mellitus	2.83e-05	0.000165	CbGpPWpGaD
Dapiprazole—ADRA1B—Signaling Pathways—EDN1—type 2 diabetes mellitus	2.83e-05	0.000165	CbGpPWpGaD
Dapiprazole—ADRA1D—Signaling Pathways—CALM1—type 2 diabetes mellitus	2.78e-05	0.000163	CbGpPWpGaD
Dapiprazole—ADRA1D—Signaling Pathways—LEP—type 2 diabetes mellitus	2.77e-05	0.000162	CbGpPWpGaD
Dapiprazole—ADRA1D—Signaling Pathways—APOE—type 2 diabetes mellitus	2.77e-05	0.000162	CbGpPWpGaD
Dapiprazole—ADRA1B—Signaling Pathways—LPL—type 2 diabetes mellitus	2.75e-05	0.000161	CbGpPWpGaD
Dapiprazole—ADRA1D—Signaling Pathways—APOA1—type 2 diabetes mellitus	2.74e-05	0.00016	CbGpPWpGaD
Dapiprazole—ADRA1A—Signaling Pathways—TGFBR2—type 2 diabetes mellitus	2.7e-05	0.000158	CbGpPWpGaD
Dapiprazole—ADRA1B—Signaling Pathways—ADCY5—type 2 diabetes mellitus	2.69e-05	0.000157	CbGpPWpGaD
Dapiprazole—ADRA1A—Signaling Pathways—GNB3—type 2 diabetes mellitus	2.68e-05	0.000157	CbGpPWpGaD
Dapiprazole—ADRA1A—Signaling Pathways—AVP—type 2 diabetes mellitus	2.64e-05	0.000154	CbGpPWpGaD
Dapiprazole—ADRA1A—Signaling Pathways—MMP3—type 2 diabetes mellitus	2.64e-05	0.000154	CbGpPWpGaD
Dapiprazole—ADRA1A—Signaling Pathways—IGF2—type 2 diabetes mellitus	2.63e-05	0.000154	CbGpPWpGaD
Dapiprazole—ADRA1A—Signaling Pathways—CDKN2B—type 2 diabetes mellitus	2.62e-05	0.000153	CbGpPWpGaD
Dapiprazole—ADRA1D—Signaling Pathways—PRKCB—type 2 diabetes mellitus	2.61e-05	0.000153	CbGpPWpGaD
Dapiprazole—ADRA1A—Signaling by GPCR—PIK3R1—type 2 diabetes mellitus	2.59e-05	0.000152	CbGpPWpGaD
Dapiprazole—ADRA1B—Signaling Pathways—PPP2CA—type 2 diabetes mellitus	2.58e-05	0.000151	CbGpPWpGaD
Dapiprazole—ADRA1A—Signaling Pathways—APOB—type 2 diabetes mellitus	2.55e-05	0.000149	CbGpPWpGaD
Dapiprazole—ADRA1A—Signaling Pathways—IGF1R—type 2 diabetes mellitus	2.54e-05	0.000149	CbGpPWpGaD
Dapiprazole—ADRA1B—Signaling Pathways—CCR5—type 2 diabetes mellitus	2.53e-05	0.000148	CbGpPWpGaD
Dapiprazole—ADRA1A—Signaling Pathways—EDN1—type 2 diabetes mellitus	2.51e-05	0.000147	CbGpPWpGaD
Dapiprazole—ADRA1D—Signaling Pathways—IRS1—type 2 diabetes mellitus	2.47e-05	0.000145	CbGpPWpGaD
Dapiprazole—ADRA1B—Signaling Pathways—C3—type 2 diabetes mellitus	2.47e-05	0.000145	CbGpPWpGaD
Dapiprazole—ADRA1A—Signaling Pathways—LPL—type 2 diabetes mellitus	2.44e-05	0.000143	CbGpPWpGaD
Dapiprazole—ADRA1A—Signaling Pathways—ADCY5—type 2 diabetes mellitus	2.39e-05	0.00014	CbGpPWpGaD
Dapiprazole—ADRA1D—Signaling Pathways—INS—type 2 diabetes mellitus	2.37e-05	0.000138	CbGpPWpGaD
Dapiprazole—ADRA1B—Signaling Pathways—HIF1A—type 2 diabetes mellitus	2.36e-05	0.000138	CbGpPWpGaD
Dapiprazole—ADRA1B—Signaling Pathways—IRS2—type 2 diabetes mellitus	2.35e-05	0.000137	CbGpPWpGaD
Dapiprazole—ADRA1B—Signaling Pathways—AGT—type 2 diabetes mellitus	2.35e-05	0.000137	CbGpPWpGaD
Dapiprazole—ADRA1D—Signaling Pathways—CCL2—type 2 diabetes mellitus	2.33e-05	0.000136	CbGpPWpGaD
Dapiprazole—ADRA1B—Signaling Pathways—CALM1—type 2 diabetes mellitus	2.31e-05	0.000135	CbGpPWpGaD
Dapiprazole—ADRA1B—Signaling Pathways—LEP—type 2 diabetes mellitus	2.3e-05	0.000135	CbGpPWpGaD
Dapiprazole—ADRA1B—Signaling Pathways—APOE—type 2 diabetes mellitus	2.3e-05	0.000135	CbGpPWpGaD
Dapiprazole—ADRA1D—Signaling Pathways—IGF1—type 2 diabetes mellitus	2.29e-05	0.000134	CbGpPWpGaD
Dapiprazole—ADRA1D—Signaling Pathways—AKT2—type 2 diabetes mellitus	2.29e-05	0.000134	CbGpPWpGaD
Dapiprazole—ADRA1A—Signaling Pathways—PPP2CA—type 2 diabetes mellitus	2.29e-05	0.000134	CbGpPWpGaD
Dapiprazole—ADRA1D—Signaling by GPCR—EGFR—type 2 diabetes mellitus	2.28e-05	0.000133	CbGpPWpGaD
Dapiprazole—ADRA1B—Signaling Pathways—APOA1—type 2 diabetes mellitus	2.28e-05	0.000133	CbGpPWpGaD
Dapiprazole—ADRA1A—Signaling Pathways—CCR5—type 2 diabetes mellitus	2.25e-05	0.000131	CbGpPWpGaD
Dapiprazole—ADRA1A—Signaling Pathways—C3—type 2 diabetes mellitus	2.2e-05	0.000128	CbGpPWpGaD
Dapiprazole—ADRA1D—Signaling Pathways—SERPINE1—type 2 diabetes mellitus	2.18e-05	0.000127	CbGpPWpGaD
Dapiprazole—ADRA1B—Signaling Pathways—PRKCB—type 2 diabetes mellitus	2.17e-05	0.000127	CbGpPWpGaD
Dapiprazole—ADRA1A—Signaling Pathways—HIF1A—type 2 diabetes mellitus	2.09e-05	0.000122	CbGpPWpGaD
Dapiprazole—ADRA1A—Signaling Pathways—IRS2—type 2 diabetes mellitus	2.09e-05	0.000122	CbGpPWpGaD
Dapiprazole—ADRA1A—Signaling Pathways—AGT—type 2 diabetes mellitus	2.09e-05	0.000122	CbGpPWpGaD
Dapiprazole—ADRA1D—Signaling Pathways—PIK3R1—type 2 diabetes mellitus	2.08e-05	0.000121	CbGpPWpGaD
Dapiprazole—ADRA1D—Signaling Pathways—NOS3—type 2 diabetes mellitus	2.08e-05	0.000121	CbGpPWpGaD
Dapiprazole—ADRA1B—Signaling Pathways—IRS1—type 2 diabetes mellitus	2.05e-05	0.00012	CbGpPWpGaD
Dapiprazole—ADRA1A—Signaling Pathways—CALM1—type 2 diabetes mellitus	2.05e-05	0.00012	CbGpPWpGaD
Dapiprazole—ADRA1A—Signaling Pathways—LEP—type 2 diabetes mellitus	2.04e-05	0.00012	CbGpPWpGaD
Dapiprazole—ADRA1A—Signaling Pathways—APOE—type 2 diabetes mellitus	2.04e-05	0.00012	CbGpPWpGaD
Dapiprazole—ADRA1A—Signaling Pathways—APOA1—type 2 diabetes mellitus	2.02e-05	0.000118	CbGpPWpGaD
Dapiprazole—ADRA1B—Signaling Pathways—INS—type 2 diabetes mellitus	1.97e-05	0.000115	CbGpPWpGaD
Dapiprazole—ADRA1D—Signaling Pathways—RELA—type 2 diabetes mellitus	1.96e-05	0.000114	CbGpPWpGaD
Dapiprazole—ADRA1B—Signaling Pathways—CCL2—type 2 diabetes mellitus	1.93e-05	0.000113	CbGpPWpGaD
Dapiprazole—ADRA1A—Signaling Pathways—PRKCB—type 2 diabetes mellitus	1.93e-05	0.000113	CbGpPWpGaD
Dapiprazole—ADRA1B—Signaling Pathways—IGF1—type 2 diabetes mellitus	1.9e-05	0.000111	CbGpPWpGaD
Dapiprazole—ADRA1B—Signaling Pathways—AKT2—type 2 diabetes mellitus	1.9e-05	0.000111	CbGpPWpGaD
Dapiprazole—ADRA1B—Signaling by GPCR—EGFR—type 2 diabetes mellitus	1.89e-05	0.000111	CbGpPWpGaD
Dapiprazole—ADRA1A—Signaling Pathways—IRS1—type 2 diabetes mellitus	1.82e-05	0.000107	CbGpPWpGaD
Dapiprazole—ADRA1B—Signaling Pathways—SERPINE1—type 2 diabetes mellitus	1.81e-05	0.000106	CbGpPWpGaD
Dapiprazole—ADRA1D—GPCR downstream signaling—AKT1—type 2 diabetes mellitus	1.78e-05	0.000104	CbGpPWpGaD
Dapiprazole—ADRA1D—Signaling Pathways—CASP3—type 2 diabetes mellitus	1.76e-05	0.000103	CbGpPWpGaD
Dapiprazole—ADRA1D—Signaling by GPCR—IL6—type 2 diabetes mellitus	1.75e-05	0.000102	CbGpPWpGaD
Dapiprazole—ADRA1A—Signaling Pathways—INS—type 2 diabetes mellitus	1.75e-05	0.000102	CbGpPWpGaD
Dapiprazole—ADRA1B—Signaling Pathways—PIK3R1—type 2 diabetes mellitus	1.72e-05	0.000101	CbGpPWpGaD
Dapiprazole—ADRA1B—Signaling Pathways—NOS3—type 2 diabetes mellitus	1.72e-05	0.000101	CbGpPWpGaD
Dapiprazole—ADRA1A—Signaling Pathways—CCL2—type 2 diabetes mellitus	1.72e-05	0.0001	CbGpPWpGaD
Dapiprazole—ADRA1A—Signaling Pathways—IGF1—type 2 diabetes mellitus	1.69e-05	9.87e-05	CbGpPWpGaD
Dapiprazole—ADRA1A—Signaling Pathways—AKT2—type 2 diabetes mellitus	1.69e-05	9.87e-05	CbGpPWpGaD
Dapiprazole—ADRA1A—Signaling by GPCR—EGFR—type 2 diabetes mellitus	1.68e-05	9.83e-05	CbGpPWpGaD
Dapiprazole—ADRA1D—Signaling Pathways—MMP9—type 2 diabetes mellitus	1.67e-05	9.74e-05	CbGpPWpGaD
Dapiprazole—ADRA1D—Signaling Pathways—NFKB1—type 2 diabetes mellitus	1.65e-05	9.64e-05	CbGpPWpGaD
Dapiprazole—ADRA1B—Signaling Pathways—RELA—type 2 diabetes mellitus	1.62e-05	9.49e-05	CbGpPWpGaD
Dapiprazole—ADRA1D—Signaling by GPCR—AKT1—type 2 diabetes mellitus	1.62e-05	9.45e-05	CbGpPWpGaD
Dapiprazole—ADRA1A—Signaling Pathways—SERPINE1—type 2 diabetes mellitus	1.6e-05	9.38e-05	CbGpPWpGaD
Dapiprazole—ADRA1D—Signaling Pathways—SRC—type 2 diabetes mellitus	1.54e-05	8.98e-05	CbGpPWpGaD
Dapiprazole—ADRA1A—Signaling Pathways—PIK3R1—type 2 diabetes mellitus	1.53e-05	8.95e-05	CbGpPWpGaD
Dapiprazole—ADRA1A—Signaling Pathways—NOS3—type 2 diabetes mellitus	1.53e-05	8.95e-05	CbGpPWpGaD
Dapiprazole—ADRA1D—Signaling Pathways—VEGFA—type 2 diabetes mellitus	1.5e-05	8.75e-05	CbGpPWpGaD
Dapiprazole—ADRA1B—GPCR downstream signaling—AKT1—type 2 diabetes mellitus	1.48e-05	8.64e-05	CbGpPWpGaD
Dapiprazole—ADRA1B—Signaling Pathways—CASP3—type 2 diabetes mellitus	1.46e-05	8.56e-05	CbGpPWpGaD
Dapiprazole—ADRA1B—Signaling by GPCR—IL6—type 2 diabetes mellitus	1.45e-05	8.5e-05	CbGpPWpGaD
Dapiprazole—ADRA1A—Signaling Pathways—RELA—type 2 diabetes mellitus	1.44e-05	8.43e-05	CbGpPWpGaD
Dapiprazole—ADRA1B—Signaling Pathways—MMP9—type 2 diabetes mellitus	1.38e-05	8.09e-05	CbGpPWpGaD
Dapiprazole—ADRA1D—Signaling Pathways—TGFB1—type 2 diabetes mellitus	1.37e-05	8.03e-05	CbGpPWpGaD
Dapiprazole—ADRA1B—Signaling Pathways—NFKB1—type 2 diabetes mellitus	1.37e-05	8e-05	CbGpPWpGaD
Dapiprazole—ADRA1D—Signaling Pathways—EGFR—type 2 diabetes mellitus	1.35e-05	7.87e-05	CbGpPWpGaD
Dapiprazole—ADRA1B—Signaling by GPCR—AKT1—type 2 diabetes mellitus	1.34e-05	7.84e-05	CbGpPWpGaD
Dapiprazole—ADRA1A—GPCR downstream signaling—AKT1—type 2 diabetes mellitus	1.31e-05	7.67e-05	CbGpPWpGaD
Dapiprazole—ADRA1A—Signaling Pathways—CASP3—type 2 diabetes mellitus	1.3e-05	7.6e-05	CbGpPWpGaD
Dapiprazole—ADRA1A—Signaling by GPCR—IL6—type 2 diabetes mellitus	1.29e-05	7.55e-05	CbGpPWpGaD
Dapiprazole—ADRA1B—Signaling Pathways—SRC—type 2 diabetes mellitus	1.28e-05	7.46e-05	CbGpPWpGaD
Dapiprazole—ADRA1B—Signaling Pathways—VEGFA—type 2 diabetes mellitus	1.24e-05	7.26e-05	CbGpPWpGaD
Dapiprazole—ADRA1A—Signaling Pathways—MMP9—type 2 diabetes mellitus	1.23e-05	7.18e-05	CbGpPWpGaD
Dapiprazole—ADRA1A—Signaling Pathways—NFKB1—type 2 diabetes mellitus	1.22e-05	7.11e-05	CbGpPWpGaD
Dapiprazole—ADRA1A—Signaling by GPCR—AKT1—type 2 diabetes mellitus	1.19e-05	6.97e-05	CbGpPWpGaD
Dapiprazole—ADRA1B—Signaling Pathways—TGFB1—type 2 diabetes mellitus	1.14e-05	6.66e-05	CbGpPWpGaD
Dapiprazole—ADRA1A—Signaling Pathways—SRC—type 2 diabetes mellitus	1.13e-05	6.62e-05	CbGpPWpGaD
Dapiprazole—ADRA1B—Signaling Pathways—EGFR—type 2 diabetes mellitus	1.12e-05	6.53e-05	CbGpPWpGaD
Dapiprazole—ADRA1A—Signaling Pathways—VEGFA—type 2 diabetes mellitus	1.1e-05	6.45e-05	CbGpPWpGaD
Dapiprazole—ADRA1D—Signaling Pathways—IL6—type 2 diabetes mellitus	1.04e-05	6.05e-05	CbGpPWpGaD
Dapiprazole—ADRA1A—Signaling Pathways—TGFB1—type 2 diabetes mellitus	1.01e-05	5.92e-05	CbGpPWpGaD
Dapiprazole—ADRA1A—Signaling Pathways—EGFR—type 2 diabetes mellitus	9.93e-06	5.8e-05	CbGpPWpGaD
Dapiprazole—ADRA1D—Signaling Pathways—AKT1—type 2 diabetes mellitus	9.55e-06	5.58e-05	CbGpPWpGaD
Dapiprazole—ADRA1B—Signaling Pathways—IL6—type 2 diabetes mellitus	8.59e-06	5.02e-05	CbGpPWpGaD
Dapiprazole—ADRA1B—Signaling Pathways—AKT1—type 2 diabetes mellitus	7.93e-06	4.63e-05	CbGpPWpGaD
Dapiprazole—ADRA1A—Signaling Pathways—IL6—type 2 diabetes mellitus	7.63e-06	4.46e-05	CbGpPWpGaD
Dapiprazole—ADRA1A—Signaling Pathways—AKT1—type 2 diabetes mellitus	7.04e-06	4.12e-05	CbGpPWpGaD
